Therapy of uncomplicated urinary tract infections.
This article deals with many options in utilizing drugs commonly used in the therapy of uncomplicated urinary tract infections (UTIs), their doses and recommended durations of treatment. In addition, it discusses general and specific accompanying measures related to the decrease in prevalence, relapses and recurrences of UTIs, including some of the factors involved in patient adherence or discontinuation of drug regimens.
Ribeiro
R M
RM
University of São Paulo, Rua Tabapuã 649-81, CEP 04533-012, São Paulo, SP, Brazil.
Rossi
P
P
Pacetta
A M
AM
Haddad
J M
JM
Pinotti
J A
JA
D042462:4-Quinolones; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D004334:Drug Administration Schedule; D005260:Female; D005578:Fosfomycin / Q000627:therapeutic use; D006801:Humans; D009582:Nitrofurantoin / Q000627:therapeutic use; D010406:Penicillins / Q000627:therapeutic use; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000627:therapeutic use; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000382:microbiology
D042462:4-Quinolones; D000890:Anti-Infective Agents; D002511:Cephalosporins; D010406:Penicillins; D005578:Fosfomycin; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D009582:Nitrofurantoin